Madison is 2 year-old female with moderate persistent asthma who weighs 12 kg. She presents with increased cough and work of breathing, a runny nose, and fevers. Based on her physical exam, laboratory results, and imaging, your team would like to treat her for an asthma exacerbation triggered by viral pneumonia. The intern calls you for help with dosing. She has already started the patient on prednisolone and albuterol. You have a reference that you can look in for pediatric doses. You look up all three medications on the dosing sheet your preceptor provided.

Drug	Concentration	Dose	Frequency
Acetaminophen	160 mg/ 5 mL	10-15 mg/kg/dose	Q 4-6 hours
Prednisolone	3 mg/mL	1-2 mg/kg/day	Q 12-24 hours
Albuterol MDI	90 mcg / puff	: 4 puffs per dose	Q 2-6 hours

What dose of acetaminophen do you recommend for Madison?

The body stores energy in various forms to ensure a constant supply of fuel during fasting or high metabolic demand. These macronutrients differ in their chemical structure and the amount of energy released upon complete oxidative catabolism. Energy density is measured in kilocalories per gram (kcal/g). Efficient storage is necessary to minimize the physical mass of the body's energy reserves.

Rationale:

A. Fat (lipids) possesses the highest energy density at approximately 9 kcal/g. This is because fatty acid chains are highly reduced hydrocarbons, allowing them to release more energy when oxidized to CO2 and water. Furthermore, fat is stored in a relatively anhydrous (water-free) state, maximizing the caloric value per unit of mass.

B. Carbohydrates provide approximately 4 kcal/g of energy. They are stored as glycogen in the liver and skeletal muscle. Glycogen is a hydrophilic molecule and is stored with a significant amount of water, which greatly reduces the overall energy-to-weight ratio compared to the dense storage found in adipose tissue.

C. This choice is scientifically incorrect as the macronutrients do not provide equal energy. The caloric yield is determined by the oxidation state of the carbon atoms in the molecule. Fats are significantly more energy-dense than both proteins and carbohydrates, yielding more than double the energy per gram than the other two.

D. Protein also provides approximately 4 kcal/g of energy. While the body can use protein for energy through gluconeogenesis or direct oxidation of carbon skeletons, it is primarily used for structural and functional purposes. Using protein as a primary energy store is inefficient and leads to the loss of muscle mass.

The Pharmacists' Patient Care Process (PPCP) provides a systematic framework for delivering consistent and effective pharmaceutical care. It emphasizes a patient-centered approach to optimize medication therapy and health outcomes. By moving through structured stages of data gathering and clinical reasoning, pharmacists ensure that therapy is indicated, effective, safe, and that patients are adherent. This process is the standard for clinical practice across all pharmacy settings.

Rationale:

A. The collect stage involves gathering essential subjective and objective information about the patient. This includes medical history, medication lists, lab results, and patient lifestyle preferences. While you must collect the medication list first, the act of identifying an interaction requires clinical analysis. Gathering the raw data is the preliminary step, but it does not encompass the actual evaluation of drug-drug compatibility.

B. The assess stage is where the pharmacist analyzes the collected information to identify medication-related problems. This involves evaluating the clinical effects of the patient’s therapy in the context of their overall health goals. Identifying drug interactions is a core component of this step, as it determines if the current regimen is safe and appropriate. It requires synthesizing data to detect potential risks to the patient.

C. The plan stage involves developing an individualized, evidence-based care plan in collaboration with other healthcare professionals and the patient. This occurs after the assessment has identified specific problems like drug interactions. The plan would include the recommendations to resolve the interaction, such as dose adjustments or medication changes. It is the strategic response to the findings discovered during the assessment phase.

D. The follow-up stage, which includes monitoring and evaluation, occurs after a plan has been implemented. The pharmacist evaluates the patient’s progress toward goals and monitors for new issues or side effects. Identifying a baseline interaction in a new patient’s record happens at the start of the care cycle. It is not part of the longitudinal monitoring that defines the follow-up/evaluation component of the PPCP.

E. The implement stage is the execution of the agreed-upon care plan. This includes providing education, administering immunizations, or initiating the recommended changes to the medication regimen. Identifying an interaction is a cognitive task of clinical reasoning that must precede implementation. You cannot implement a solution until you have first performed the clinical assessment to identify the underlying medication problem.